In the present study, we found that elevated plasma VAP-1 levels were independently associated with MACE in patients with AF, the occurrence of MACE events increased with increasing VAP-1 levels after a maximum follow-up of 35 weeks. Here, AOC3 is linked to atrial fibrillation.